NASDAQ$OSUR

OraSure Technologies Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

OraSure's Q3 2024 financial performance reflected revenue of $39.9 million and GAAP EPS of $(0.06).

OraSure Technologies reported Q3 2024 revenue of $39.9 million, a 55% decrease compared to Q3 2023. Core revenues decreased by 1% year-over-year, while COVID-19 revenues declined significantly. The company is exiting its Risk Assessment testing business to focus on Diagnostics and Sample Management.

  • Q3 2024 revenue was $39.9 million, a 55% decrease year-over-year.
  • Core revenues decreased 1% year-over-year, with Diagnostics up 13% and Molecular Sample Management down 16%.
  • COVID-19 revenues decreased 96% year-over-year to $2.2 million.
  • The company is exiting the Risk Assessment testing business to focus on growth opportunities in Diagnostics and Sample Management.

Headline financials

Total Revenue

$39.9M

Previous: $89.2M-55.2%
EPS

-$0.06

Previous: $0.27-122.2%
Gross Margin

42.8%

No prior period
Non-GAAP Gross Margin

43.3%

No prior period
Operating Margin

-15.0%

No prior period
Non-GAAP Operating Margin

-6.8%

No prior period
Capital Expenditures

-$3.34M

Previous: -$4.52M+26.0%
Free Cash Flow

-$7.85M

Previous: $6.64M-218.2%
Net Income

-$4.51M

Previous: $11.2M-140.4%
Operating Income

-$6M

Previous: $10.9M-155.1%
Gross Profit

$17.1M

Previous: $44.3M-61.5%
Cash & Equivalents

$279M

Previous: $218M+28.1%
Total Assets

$464M

Previous: $458M+1.2%
R&D Expense

$5.62M

Previous: $8.52M-34.0%
Stock-Based Comp

$2.89M

Previous: $2.59M+11.5%

Revenue & EPS history

OraSure · Revenue · Quarterly

$39.9M

Q3 2024-55.2%vs Q3 2023
Beat estimate in 13 of 14 quarters(93%)
ActualEstimate

Forward guidance

The Company is guiding to Q4 2024 revenues of $36 to $38 million. The Company anticipates Core revenues in Q4 2024 of $35 to $37 million, which includes $1 to $2 million of Risk Assessment testing revenues. The Company anticipates COVID-19 revenues in Q4 2024 of approximately $1 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-2.1%

Avg return

Earnings day

+0.4%

Avg return

5 days after

-2.4%

Avg return

30 days after

39%

25 / 64 earnings

Positive

+31.7%

Q2 2023

Best reaction

-32.1%

Q2 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.2%-2.9%
Q4 2025+10.0%+6.4%+7.1%
Q3 2025-6.6%-4.3%-3.1%
Q1 2025-6.8%-5.0%+3.6%
Q4 2024-23.5%-10.8%-14.2%
Q3 2024-1.2%-1.2%-8.9%
Q2 2024+2.6%-0.2%+5.7%
Q1 2024-8.8%-6.9%-15.3%
Q4 2023+10.3%+3.7%-12.3%
Q3 2023+4.9%+14.5%+22.2%
Q2 2023+31.7%+43.9%+42.8%
Q1 2023+9.2%-20.8%-22.3%
Q4 2022+10.4%+18.8%+30.1%
Q3 2022+0.7%+20.8%+18.5%
Q2 2022+28.3%+38.6%+18.8%
Q1 2022-8.9%-3.9%-48.8%
Q4 2021-1.3%-0.8%-13.0%
Q3 2021-4.9%-7.7%-19.8%
Q2 2021+1.2%-0.7%-4.1%
Q1 2021+5.0%+5.1%+0.2%
Q4 2020-2.3%+2.1%+1.5%
Q3 2020-15.6%-15.4%-20.6%
Q2 2020-32.1%-24.6%-46.9%
Q1 2020+6.1%+15.6%-33.1%
Q4 2019-6.7%-6.1%+8.5%
Q3 2019-3.1%-6.9%-10.3%
Q2 2019-3.3%-5.2%-14.4%
Q1 2019-8.0%-12.6%-12.7%
Q4 2018-25.5%-18.3%-14.8%
Q3 2018-8.7%-6.6%-15.0%
Q2 2018-0.6%-1.0%-5.8%
Q1 2018-15.4%-11.0%-2.4%
Q4 2017-12.8%-13.4%-9.5%
Q3 2017-30.3%-26.6%-13.8%
Q2 2017+13.5%+19.4%+17.4%
Q1 2017+16.9%+10.9%+17.6%
Q4 2016+18.9%+18.9%+29.9%
Q3 2016-0.1%+1.4%+14.3%
Q2 2016+4.6%+8.5%+30.7%
Q1 2016-6.6%
Q4 2015+14.7%
Q3 2015+0.4%
Q2 2015+7.0%
Q1 2015-12.3%
Q4 2014-11.9%
Q3 2014+2.9%
Q2 2014-7.7%
Q1 2014-9.2%
Q4 2013+9.5%
Q3 2013-0.3%
Q2 2013+10.2%
Q1 2013-0.4%
Q4 2012-12.4%
Q3 2012-16.4%
Q2 2012-7.1%
Q1 2011+5.0%
Q1 2012-5.9%
Q4 2011+4.6%
Q3 2011-5.6%
Q4 2010-12.5%
Q2 2011-12.5%
Q3 2010+6.6%
Q2 2010-7.0%
Q1 2010-15.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro